Clinical Trial: Dynamic Splinting for Plantarflexion in Spastic Hemiplegia
Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title: Dynamic Splinting for Excessive Plantarflexion in Patients With Spastic Hemiplegia: A Randomized, Controlled Study of Gait Analysis
Brief Summary: The purpose of this study is to examine the effectiveness of onabotulinum toxin A (BTX) injections (tone management) and dynamic splinting (contracture reduction) for improving gait patterns in patients with spastic hypertnoia due to stroke or traumatic brain injury and resultant excessive plantarflexion.
Detailed Summary:
Sponsor: Dynasplint Systems, Inc.
Current Primary Outcome: Change in gait pattern [ Time Frame: 12 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Dynasplint Systems, Inc.
Dates:
Date Received: April 4, 2011
Date Started: May 2011
Date Completion: August 2015
Last Updated: August 8, 2013
Last Verified: August 2013